自闭症幼儿关键反应治疗 (PRT) 改善的神经影像学预测因子 (PRT-I)
Autism spectrum disorder (ASD) is a very heterogeneous disorder with limited empirically validated behavioral and biological interventions. The goal of this pilot investigation is to apply a biologically-based approach to identify predictors of treatment response in children with ASD who are receiving Pivotal Response Treatment (PRT), an evidence-based behavioral intervention. Specifically, the investigators propose to identify neuroimaging biomarkers of treatment response to a PRT program (PRT-P) targeting language deficits in young children with ASD who will be randomized to either PRT-P or to a delayed treatment group (DTG).
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Estefania Millan, MA
- 电话号码:(650) 736-1235
- 邮箱:mmillan2@stanford.edu
研究联系人备份
- 姓名:John Hegarty, PhD
- 电话号码:(650) 736-1235
- 邮箱:hegartyj@stanford.edu
学习地点
-
-
California
-
Stanford、California、美国、94305-5719
- 招聘中
- Stanford University
-
首席研究员:
- Antonio Y. Hardan, MD
-
接触:
- Estefania Millan, MA
- 电话号码:(650) 736-1235
- 邮箱:mmillan2@stanford.edu
-
接触:
- Robin Libove, BS
- 电话号码:(650) 736-1235
- 邮箱:rlibove@stanford.edu
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Diagnosis of Autism Spectrum Spectrum Disorder (ASD) based on clinical interview and Diagnostic and Statistical Manual, 5th edition (DSM-5) and confirmed using the Autism Diagnostic Interview Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS) and/or Brief Observation of Symptoms of Autism (BOSA) and/or Childhood Autism Rating Scale- Second Edition (CARS-2).
- Outpatients between 2.0 and 4.11 years of age of either gender,
- Children of all cognitive levels will be included as long as they are able to participate in the testing procedures to the extent that valid standard scores can be obtained
- Language delay as measured by the Preschool Language Scale, 5th Edition (PLS-5) [at least 1 standard deviation behind for children age 2 and 3 years; and 2 standard deviations behind for children age 4],
- Stable psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation,
- Stable treatment [Applied Behavior Analysis (ABA), Floortime, or other interventions], speech therapy, and school placement for at least 1 month prior to baseline measurements with no expected changes during study participation,
- No more than 60 minutes of 1:1 speech therapy per week,
- The child's exposure to the English language must be sufficient that administration of standardized tests in English is appropriate for measuring progress,
- The availability of at least one parent who can consistently participate in the training sessions and related activities, and
- Successful completion of baseline brain scan.
Exclusion Criteria:
- Current or life-time diagnosis of severe psychiatric disorder (e.g., bipolar disorder),
- Genetic abnormality (e.g., Fragile X)
- Presence of active medical problem (e.g., unstable seizure disorder),
- Receiving more than 15 hours of in home 1:1 Applied Behavior Analysis (ABA) per week
- Magnetic Resonance (MR) contraindication (e.g., the presence of ferrous metal), or
- Previous adequate Pivotal Response Treatment (PRT) trial.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Pivotal Response Treatment Program (PRT-P)
The Pivotal Response Treatment Program (PRT-P) will consist of 3 parent-only sessions (60-90 min) and 13 family sessions with the parent and child (60-90 min). These 16 sessions are once per week over a 16 week period. |
The Pivotal Response Treatment Program (PRT-P) will consist of 3 parent-only sessions (60-90 min) and 13 family sessions with the parent and child (60-90 min). These 16 sessions are once per week over a 16 week period.
其他名称:
|
|
无干预:Delayed Treatment Group (DTG)
Child continues stable treatments as usual in the community. |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
结构化实验室观察 (SLO) 期间儿童话语数量的变化
大体时间:基线,16 周
|
基线,16 周
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
MacArthur-Bates 通信发展清单 (CDI) 的变化
大体时间:基线,16 周
|
基线,16 周
|
其他结果措施
结果测量 |
大体时间 |
|---|---|
|
学龄前语言量表变化,第 5 版 (PLS-5)
大体时间:基线,16 周
|
基线,16 周
|
|
Mullen 早期学习量表的变化
大体时间:基线,16 周
|
基线,16 周
|
|
Vineland 适应性行为量表的变化,第 3 版
大体时间:基线,16 周
|
基线,16 周
|
|
临床整体印象量表 (CGI) 的变化
大体时间:基线,16 周
|
基线,16 周
|
|
改变对社会沟通变化的简要观察(BOSCC)直接儿童观察评估
大体时间:基线,16 周
|
基线,16 周
|
|
父母压力指数 (PSI) 的变化
大体时间:基线,16 周
|
基线,16 周
|
|
家庭赋权量表 (FES) 的变化
大体时间:基线,16 周
|
基线,16 周
|
|
一般自我效能感量表 (GSES) 的变化
大体时间:基线,16 周
|
基线,16 周
|
合作者和调查者
调查人员
- 首席研究员:Antonio Hardan, MD、Stanford University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- IRB-46131
- 1R21DC016089-01A1 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
We will submit de-identified clinical data to the NIMH Data Archive (NDA) data repository.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.